section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
Press releases QMUL Press release UCL Press release Nature Medicine Research Briefing Blood proteins predict the risk of many diseases years before onset.
section {
background: white;
color: black;
border-radius: 1em;
padding: 1em;
left: 50% }
#inner {
display: inline-block;
display: flex;
align-items: center;
justify-content: center }
Twitter thread summarising key results
Phenotyping at scale across diverse biobank cohorts to power genomic & proteomic analyses for target identification, drug discovery, and precision medicine.
Underpinned by the needs of patients, clinicians and researchers, the Disease Atlas is an ambitious project involving the generation of a systematic, data-driven knowledge across all common and rare diseases. Using newly available nationwide data on 56 million people the Atlas is generating novel comparative insights of the health needs of patients, the care provided, and the research that is carried out.
A joint webinar hosted by National Institute for Health Research (NIHR) and British Heart Foundation (BHF) Data Science Centre for NIHR supported COVID-19 studies, to highlight how to utilise and access routinely-collected healthcare data via NHS Digital’s Trusted Research Environment, the UK’s largest linked health data research asset.
Short presentation of our progress on defining COVID-19 event phenotypes in the NHS-Digital Trusted Research Environment as part of the CVD-COVID-UK Consortium.